London-based insurtech company Artificial Labs has successfully raised $45 million in its Series B funding round, marking a major milestone in the insurance technology sector.
The funding was led by CommerzVentures, with support from Move Capital Fund I and participation from existing investors 6 Degrees Capital, Augmentum Fintech, Force Over Mass, and TrueSight Ventures, underscoring strong confidence in the company’s algorithmic underwriting platform.
Background and History of Artificial Labs
Founded in 2013, Artificial Labs has been focused on digitising insurance operations, beginning with software that automates complex underwriting, risk assessment, and policy management processes for brokers and carriers.
The company leverages data-driven technology to replace manual workflows, helping insurers reduce errors, improve efficiency, and scale operations more effectively.
Impact of the Recent Funding
The Series B capital will enable Artificial Labs to further enhance its platform, particularly in areas such as real-time risk modelling and predictive analytics, while supporting the needs of larger enterprise customers.
The company’s technology is already used by major insurance players, including Lloyd’s of London, demonstrating its impact in high-value insurance environments.
Future Prospects and Market Outlook
Looking ahead, Artificial Labs plans to expand into additional markets across Europe and North America, where demand for modern insurance infrastructure continues to grow.
“This round gives us the room to grow with confidence,” said David King, co-founder of Artificial Labs, noting that the company is well-positioned to support brokers and carriers as they modernise how they operate.
Andrew Lee
